163 related articles for article (PubMed ID: 10628466)
1. Imaging features of posttransplantation lymphoproliferative disorder in pancreas transplant recipients.
Meador TL; Krebs TL; Cheong JJ; Daly B; Keay S; Bartlett S
AJR Am J Roentgenol; 2000 Jan; 174(1):121-4. PubMed ID: 10628466
[TBL] [Abstract][Full Text] [Related]
2. Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population.
Miller WT; Siegel SG; Montone KT
Crit Rev Diagn Imaging; 1997 Dec; 38(6):569-85. PubMed ID: 9442979
[TBL] [Abstract][Full Text] [Related]
3. Focal posttransplantation lymphoproliferative disorder at the renal allograft hilum.
Lopez-Ben R; Smith JK; Kew CE; Kenney PJ; Julian BA; Robbin ML
AJR Am J Roentgenol; 2000 Nov; 175(5):1417-22. PubMed ID: 11044055
[TBL] [Abstract][Full Text] [Related]
4. Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients.
Lim GY; Newman B; Kurland G; Webber SA
Radiology; 2002 Mar; 222(3):699-708. PubMed ID: 11867788
[TBL] [Abstract][Full Text] [Related]
5. Posttransplantation lymphoproliferative disorder in children: manifestations in hematopoietic cell recipients in comparison with liver recipients.
Jeon TY; Kim JH; Eo H; Yoo SY; Yoo KH; Lee SK; Lim GY; Cheon JE
Radiology; 2010 Nov; 257(2):490-7. PubMed ID: 20829531
[TBL] [Abstract][Full Text] [Related]
6. Posttransplant lymphoproliferative disorder: a pictorial review.
Burney K; Bradley M; Buckley A; Lyburn I; Rye A; Hopkins R
Australas Radiol; 2006 Oct; 50(5):412-8. PubMed ID: 16981935
[TBL] [Abstract][Full Text] [Related]
7. Posttransplant lymphoproliferative disorder following pancreas transplantation.
Issa N; Amer H; Dean PG; Kremers WK; Kudva YC; Rostambeigi N; Cosio FG; Larson TS; Habermann TM; Stegall MD; Griffin MD
Am J Transplant; 2009 Aug; 9(8):1894-902. PubMed ID: 19519812
[TBL] [Abstract][Full Text] [Related]
8. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
9. Post-transplantation lymphoproliferative disorders in renal vs. simultaneous renal-pancreas allograft recipients: a survey and analysis of data from the literature.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):1-7. PubMed ID: 23354184
[TBL] [Abstract][Full Text] [Related]
10. Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of disease.
Wilde GE; Moore DJ; Bellah RD
AJR Am J Roentgenol; 2005 Nov; 185(5):1335-41. PubMed ID: 16247159
[TBL] [Abstract][Full Text] [Related]
11. CT of posttransplantation lymphoproliferative disorder in pediatric recipients of lung allograft.
Siegel MJ; Lee EY; Sweet SC; Hildebolt C
AJR Am J Roentgenol; 2003 Oct; 181(4):1125-31. PubMed ID: 14500243
[TBL] [Abstract][Full Text] [Related]
12. Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients.
Pickhardt PJ; Siegel MJ
Radiology; 1999 Oct; 213(1):73-8. PubMed ID: 10540643
[TBL] [Abstract][Full Text] [Related]
13. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
Filipec-Kanizaj T; Budimir J; Colić-Cvrlje V; Kardum-Skelin I; Sustercić D; Naumovski-Mihalić S; Mrzljak A; Kolonić SO; Sobocan N; Bradić T; Dolić ZM; Kocman B; Katicić M; Zidovec-Lepej S; Vince A
Acta Med Croatica; 2011 Sep; 65 Suppl 1():37-43. PubMed ID: 23126028
[TBL] [Abstract][Full Text] [Related]
14. Mutlifocal osseous posttransplantation lymphoproliferative disorder: case report.
Lo R; Michalicek Z; Lazarus M
Skeletal Radiol; 2015 Jul; 44(7):1021-6. PubMed ID: 25680332
[TBL] [Abstract][Full Text] [Related]
15. Posttransplantation lymphoproliferative disorder of the head and neck: imaging features in seven adults.
Loevner LA; Karpati RL; Kumar P; Yousem DM; Hsu W; Montone KT
Radiology; 2000 Aug; 216(2):363-9. PubMed ID: 10924554
[TBL] [Abstract][Full Text] [Related]
16. Tumorous intrahepatic lymphoproliferative disorder in transplanted livers.
Strouse PJ; Platt JF; Francis IR; Bree RL
AJR Am J Roentgenol; 1996 Nov; 167(5):1159-62. PubMed ID: 8911173
[TBL] [Abstract][Full Text] [Related]
17. Increased beta 2-microglobulin (B2M) is useful in the detection of post-transplant lymphoproliferative disease (PTLD).
Sasaki TM; Pirsch JD; D'Alessandro AM; Knechtle SJ; Kalayoglu M; Hafez GR; Sollinger HW
Clin Transplant; 1997 Feb; 11(1):29-33. PubMed ID: 9067691
[TBL] [Abstract][Full Text] [Related]
18. Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipients.
Keay S; Oldach D; Wiland A; Klassen D; Schweitzer E; Abruzzo LV; Kumar D; Bartlett S
Clin Infect Dis; 1998 Mar; 26(3):596-600. PubMed ID: 9524829
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
20. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
